Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Thiazolidinecarboxylic acid, 3-[(4-methoxyphenyl)methyl]-2-oxo-, (R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

139944-38-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 139944-38-0 Structure
  • Basic information

    1. Product Name: 4-Thiazolidinecarboxylic acid, 3-[(4-methoxyphenyl)methyl]-2-oxo-, (R)-
    2. Synonyms:
    3. CAS NO:139944-38-0
    4. Molecular Formula: C12H13NO4S
    5. Molecular Weight: 267.306
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 139944-38-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-Thiazolidinecarboxylic acid, 3-[(4-methoxyphenyl)methyl]-2-oxo-, (R)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-Thiazolidinecarboxylic acid, 3-[(4-methoxyphenyl)methyl]-2-oxo-, (R)-(139944-38-0)
    11. EPA Substance Registry System: 4-Thiazolidinecarboxylic acid, 3-[(4-methoxyphenyl)methyl]-2-oxo-, (R)-(139944-38-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 139944-38-0(Hazardous Substances Data)

139944-38-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 139944-38-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,9,4 and 4 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 139944-38:
(8*1)+(7*3)+(6*9)+(5*9)+(4*4)+(3*4)+(2*3)+(1*8)=170
170 % 10 = 0
So 139944-38-0 is a valid CAS Registry Number.

139944-38-0Downstream Products

139944-38-0Relevant articles and documents

Structure-Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity

Varghese, Swapna,Rahmani, Rapha?l,Drew, Damien R.,Beeson, James G.,Baum, Jake,Smith, Brian J.,Baell, Jonathan B.

, p. 679 - 693 (2020/11/30)

Malarial parasites employ actin dynamics for motility, and any disruption to these dynamics renders the parasites unable to effectively establish infection. Therefore, actin presents a potential target for malarial drug discovery, and naturally occurring actin inhibitors such as latrunculins are a promising starting point. However, the limited availability of the natural product and the laborious route for synthesis of latrunculins have hindered their potential development as drug candidates. In this regard, we recently described novel truncated latrunculins, with superior actin binding potency and selectivity towards P. falciparum actin than the canonical latrunculin B. In this paper, we further explore the truncated latrunculin core to summarize the SAR for inhibition of malaria motility. This study helps further understand the binding pattern of these analogues in order to develop them as drug candidates for malaria.

Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B

Fuerstner, Alois,De Souza, Dominic,Turet, Laurent,Fenster, Michael D. B.,Parra-Rapado, Liliana,Wirtz, Conny,Mynott, Richard,Lehmann, Christian W.

, p. 115 - 134 (2007/10/03)

The latrunculins are highly selective actin-binding marine natural products and as such play an important role as probe molecules for chemical biology. A short, concise and largely catalysis-based approach to this family of bioactive macrolides is presented. Specifically, the macrocyclic skeletons of the targets were forged by ring-closing alkyne metathesis (RCAM) or enyne-yne metathesis of suitable diyne or enyne-yne precursors, respectively. This transformation was best achieved with the aid of [(tBu)(Me2C6H 3)N]3Mo (37) as precatalyst activated in situ with CH 2Cl2, as previously described. This catalyst system is strictly chemoselective for the triple bond and does not affect the olefinic sites of the substrates. Moreover, the molybdenum-based catalyst turned out to be broader in scope than the Schrock alkylidyne complex [(tBuO)3 W≡CMe3] (38), which afforded cycloalkyne 35 in good yield but failed in closely related cases. The required metathesis precursors were assembled in a highly convergent fashion from three building blocks derived from acetoacetate, cysteine. and (+)-citronellene. The key fragment coupling can either be performed via a titanium aldol reaction or, preferentially, by a sequence involving a Horner-Wadsworth-Emmons olefination followed by a protonation/cyclization/diastereoselective hydration cascade. Iron-catalyzed C-C-bond formations were used to prepare the basic building blocks in an efficient manner. This synthesis blueprint gave access to latrunculin B (2), its naturally occurring 16-epimer 3, as well as the even more potent actin binder latrunculin A (1) in excellent overall yields. Because of the sensitivity of the 1,3-diene motif of the latter, however, the judicious choice of protecting groups and the proper phasing of their cleavage was decisive for the success of the total synthesis. Since latrunculin A and B had previously been converted into latrunculin S, C and M, respectively, formal total syntheses of these congeners have also been achieved. Finally, a previously unknown acid-catalyzed degradation pathway of these bioactive natural products is described. The cysteine-derived ketone 18, the tetrahydropyranyl segment 31 serving as the common synthesis platform for the preparation of all naturally occurring latrunculins, as well as the somewhat strained cycloalkyne 35 formed by the RCAM reaction en route to 2 were characterized by X-ray crystallography.

PROCESS FOR THE PREPARATION OF 3,4-DISUBSTITUTED-THIAZOLIDIN-2-ONES

-

Page/Page column 12; 14-15, (2010/11/28)

The present invention is directed to practical high-yielding synthetic processes for preparing 3,4-disubstituted-thiazolidin-2-ones, which do not compromise the absolute stereochemical integrity of the compounds. The present invention is also directed to

Cytoskeletal active compounds, compositions and use

-

Page/Page column 19; 20, (2010/11/23)

The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically

Catalysis-Based Total Synthesis of Latrunculin B

Fuerstner, Alois,De Souza, Dominic,Parra-Rapado, Liliana,Jensen, Jon T.

, p. 5358 - 5360 (2007/10/03)

The highly selective actin-binding latrunculins (e.g. 1) play a prominent role as probe molecules in chemical biology. A highly concise, productive, and inherently flexible approach to 1 illustrates the excellent profile and use of metal-catalyzed C-C bond formations.

Total synthesis of the latrunculins

Smith III, Amos B.,Leahy, James W.,Noda, Ichio,Remiszewski, Stacy W.,Liverton, Nigel J.,Zibuck, Regina

, p. 2995 - 3007 (2007/10/02)

The total syntheses of (+)-latrunculin A (1) and (+)-latrunculin B (2), two architecturally novel toxins isolated from the Red Sea sponge Latrunculia magnifica (Keller), have been achieved via highly convergent and stereocontrolled routes (longest linear sequences, 16 and 12 steps, respectively). Formal syntheses of scalemic latrunculins C (3) and M (5) also derive from the construction of 2. Central features of the unified synthetic strategy include the aldol reaction of aldehyde (-)-12 with methyl ketone (-)-13, a novel acid-catalyzed reorganization-equilibration of ortho ester (-)-11, and Mitsunobu macrolide cyclization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 139944-38-0